Back to Search
Start Over
GPIIb/IIIa autoantibody predicts better rituximab response in ITP.
- Source :
- British Journal of Haematology; Jul2018, Vol. 182 Issue 2, p305-307, 3p, 1 Chart, 1 Graph
- Publication Year :
- 2018
-
Abstract
- The article discusses the relationship between antibody specificities and efficacy of rituximab in patients with primary immune thrombocytopenia (ITP). The authors discovered that patients with anti-GPIIb/IIIa autoantibodies responded more to rituximab therapy. Autoantibody specificity was found before rituximab therapy using modified monoclonal antibody immobilization of platelet antigen assay.
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 182
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 130603707
- Full Text :
- https://doi.org/10.1111/bjh.14782